Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter McIntyre

Showing results (181-190 of 235) with videos related to

Pageof 24
Sort By:
The Journal of Biological Chemistry|May 10, 2012
N-glycosylation determines ionic permeability and desensitization of the TRPV1 capsaicin receptorNicholas A Veldhuis, Michael J Lew, Fe C Abogadie, et al.
Vaccine|June 7, 2016
Transiently increased IgE responses in infants and pre-schoolers receiving only acellular Diphtheria-Pertussis-Tetanus (DTaP) vaccines compared to those initially receiving at least one dose of cellular vaccine (DTwP) - Immunological curiosity or canary in the mine?Patrick G Holt, Tom Snelling, Olivia J White, et al.
Vaccine|December 20, 2011
The changing and dynamic epidemiology of meningococcal diseaseScott A Halperin, Julie A Bettinger, Brian Greenwood, et al.
The Journal of Biological Chemistry|January 5, 2013
Protease-activated receptor 2 (PAR2) protein and transient receptor potential vanilloid 4 (TRPV4) protein coupling is required for sustained inflammatory signalingDaniel P Poole, Silvia Amadesi, Nicholas A Veldhuis, et al.
Plos One|March 21, 2025
Immunogenicity and safety of measles-mumps-rubella vaccine delivered by the aerosol, intradermal and intramuscular routes in previously vaccinated young adults: a randomized controlled trial protocolSumanta Saha, Melanie Millier, Ari Samaranayaka, et al.
The Pediatric Infectious Disease Journal|March 10, 2025
Acellular Pertussis Vaccine Given in the Week After Birth Does Not Impair Antibody Responses to Later Childhood DosesSonia M McAlister, Anita H J van den Biggelaar, Matthew N Cooper, et al.
Vaccine|June 5, 2018
Assessment of on-time vaccination coverage in population subgroups: A record linkage cohort studyHannah C Moore, Parveen Fathima, Heather F Gidding, et al.
The Lancet Regional Health. Western Pacific|November 11, 2024
RSV severity in New Zealand 2021 and 2022: applying the WHO severity assessment frameworkDavid Broderick, Isabella Cheung, Janine Paynter, et al.
Communicable Diseases Intelligence (2018)|August 16, 2019
Vaccine Preventable Diseases and Vaccination Coverage in Aboriginal and Torres Strait Islander People, Australia, 2011–2015, Sally Ioannides, Frank Beard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 8, 2019
Long-term Impact of Pneumococcal Conjugate Vaccines on Invasive Disease and Pneumonia Hospitalizations in Indigenous and Non-Indigenous AustraliansKelley N Meder, Sanjay Jayasinghe, Frank Beard, et al.
Pageof 24

Showing results (181-190 of 235) with videos related to

Sort By:
Pageof 24
The Journal of Biological Chemistry|May 10, 2012
N-glycosylation determines ionic permeability and desensitization of the TRPV1 capsaicin receptorNicholas A Veldhuis, Michael J Lew, Fe C Abogadie, et al.
Vaccine|June 7, 2016
Transiently increased IgE responses in infants and pre-schoolers receiving only acellular Diphtheria-Pertussis-Tetanus (DTaP) vaccines compared to those initially receiving at least one dose of cellular vaccine (DTwP) - Immunological curiosity or canary in the mine?Patrick G Holt, Tom Snelling, Olivia J White, et al.
Vaccine|December 20, 2011
The changing and dynamic epidemiology of meningococcal diseaseScott A Halperin, Julie A Bettinger, Brian Greenwood, et al.
The Journal of Biological Chemistry|January 5, 2013
Protease-activated receptor 2 (PAR2) protein and transient receptor potential vanilloid 4 (TRPV4) protein coupling is required for sustained inflammatory signalingDaniel P Poole, Silvia Amadesi, Nicholas A Veldhuis, et al.
Plos One|March 21, 2025
Immunogenicity and safety of measles-mumps-rubella vaccine delivered by the aerosol, intradermal and intramuscular routes in previously vaccinated young adults: a randomized controlled trial protocolSumanta Saha, Melanie Millier, Ari Samaranayaka, et al.
The Pediatric Infectious Disease Journal|March 10, 2025
Acellular Pertussis Vaccine Given in the Week After Birth Does Not Impair Antibody Responses to Later Childhood DosesSonia M McAlister, Anita H J van den Biggelaar, Matthew N Cooper, et al.
Vaccine|June 5, 2018
Assessment of on-time vaccination coverage in population subgroups: A record linkage cohort studyHannah C Moore, Parveen Fathima, Heather F Gidding, et al.
The Lancet Regional Health. Western Pacific|November 11, 2024
RSV severity in New Zealand 2021 and 2022: applying the WHO severity assessment frameworkDavid Broderick, Isabella Cheung, Janine Paynter, et al.
Communicable Diseases Intelligence (2018)|August 16, 2019
Vaccine Preventable Diseases and Vaccination Coverage in Aboriginal and Torres Strait Islander People, Australia, 2011–2015, Sally Ioannides, Frank Beard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 8, 2019
Long-term Impact of Pneumococcal Conjugate Vaccines on Invasive Disease and Pneumonia Hospitalizations in Indigenous and Non-Indigenous AustraliansKelley N Meder, Sanjay Jayasinghe, Frank Beard, et al.
Pageof 24